ENZACTA R & D LTD has a total of 17 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, biotechnology and micro-structure and nano-technology are IMMUNOTHERAPEUTICS INC, SYNZYME TECHNOLOGIES INC and AKADEMIA MEDYCZNA IM PIASTOW SLASKICH WE WROCLAWIU.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United Kingdom | 3 | |
#4 | Canada | 2 | |
#5 | Hong Kong | 2 | |
#6 | Australia | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Micro-structure and nano-technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Bagshawe Kenneth Dawson | 7 |
#2 | Knox Richard John | 7 |
#3 | Burke Philip John | 7 |
#4 | Richard John Knox | 1 |
#5 | Burke Philip J | 1 |
#6 | Knox Richard J | 1 |
#7 | Philip John Burke | 1 |
Publication | Filing date | Title |
---|---|---|
GB0128004D0 | System for treatment | |
GB0126082D0 | Therapeutic systems |